Telix Pharmaceuticals (TLX: ASX) has announced a definitive agreement to acquire key assets from ImaginAb, a specialist in antibody engineering. The deal will see Telix bolster its pipeline with early ...

While the pandemic has been the focus of R&D attention for much of 2020, that is slowly beginning to shift towards other projects in the big pharma pipeline. pharmaphorum’s news editor ...

13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively ... Phase III study interim analysis.

These strategic developments, along with a robust valuation analysis, underpin the optimistic outlook toward Innate Pharma, supporting the Buy rating with a price target of $11.50. According to ...

13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively ... a comparative analysis of clinical and non-clinical stage ...

Find Pipeline Infographic stock video, 4K footage, and other HD footage from iStock. Get higher quality Pipeline Infographic content, for less—All of our 4K video clips are the same price as HD. Video ...

and streamline your search for investment opportunities using Tipranks' Stock Screener Tazeen Ahmad’s rating is based on Inozyme Pharma’s promising pipeline and market potential. The company ...

In fact, the current challenges facing the pharmaceutical industry are formidable and include the need to bring innovative products given poor late-stage pipelines, low numbers of new chemical ...